Telix to Acquire IsoTherapeutics (US R&D and Manufacturing)
Filed with ASX · · 3 pages · English
Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20Read the transcript of Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings CallTelix Pharmaceuticals Limited on 6ix
Earlier from Telix Pharmaceuticals
- 2023 Full Year Results Presentation
- Appendix 4E and 2023 Annual Report
- 2023 Full Year Results Release
- Telix Acquires QSAM and its Bone Cancer Targeting Platform
- Presentation to Accompany QSAM Acquisition
Later from Telix Pharmaceuticals
- Presentation to Accompany ARTMS Acquisition
- Telix to Acquire ARTMS (Isotope Production Platform)
- Telix General Meeting Chairman and CEO Addresses
- Telix General Meeting Presentation
- Telix Completes Acquisition of IsoTherapeutics
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals